Magnesium oxide and Fluocinonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium oxide (magnesium) and Fluocinonide (fluocinonide). Common drug interactions include progesterone receptor assay positive among females and purpura among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium oxide and Fluocinonide. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium oxide?

Magnesium oxide has active ingredients of magnesium. It is often used in migraine. eHealthMe is studying from 19,022 Magnesium oxide users. Check the latest studies of Magnesium oxide.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.



On Jul, 19, 2026

35 people who take Magnesium oxide and Fluocinonide together, and have interactions are studied.

Magnesium oxide and Fluocinonide drug interactions.

What are the common drug interactions of Magnesium Oxide and Fluocinonide, by gender? *:

female:

  1. Progesterone receptor assay positive
  2. Pruritus (severe itching of the skin)
  3. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  4. Rash
  5. Sacroiliitis (an inflammation of the sacroiliac joint)
  6. Sensation of heaviness
  7. Cough
  8. Pneumonia
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Tooth abscess (pus formation in tooth)

male:

  1. Purpura (purplish discoloration of the skin)
  2. Rash pruritic (redness with itching)
  3. Peripheral swelling
  4. Rash erythematous (redness of the skin)
  5. Abdominal discomfort
  6. Decreased appetite
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Oedema peripheral (superficial swelling)
  9. Type 2 diabetes mellitus
  10. Abdominal distension

What are the common drug interactions of Magnesium Oxide and Fluocinonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood albumin decreased
  2. Hypersensitivity

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Asthenia (weakness)
  4. Bone cyst
  5. Bone density decreased
  6. Cerebral haemorrhage (bleeding within the brain)
  7. Chronic kidney disease
  8. Depression
  9. Emotional distress
  10. Mobility decreased (ability to move is reduced)

50-59:

  1. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  2. Vulval abscess
  3. Anal abscess
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Anxiety
  6. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  7. Aortic valve replacement
  8. Arteriosclerosis (thickening and hardening of arteries)
  9. Breast cancer
  10. Breast cyst

60+:

  1. Cough
  2. Pneumonia
  3. Apathy
  4. Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
  5. Joint swelling
  6. Laziness
  7. Multiple allergies (allergy to multiple agents)
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Oedema peripheral (superficial swelling)
  10. Rash erythematous (redness of the skin)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 9 people, 25.71%
  2. Bacterial Infection: 7 people, 20.00%
  3. Cough: 7 people, 20.00%
  4. Itching: 6 people, 17.14%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 17.14%
  6. Anaemia (lack of blood): 4 people, 11.43%
  7. Constipation: 4 people, 11.43%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.57%
  9. Multiple Myeloma (cancer of the plasma cells): 3 people, 8.57%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium oxide and Fluocinonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Magnesium oxide and Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium oxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium oxide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluocinonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on magnesium and fluocinonide (the active ingredients of Magnesium oxide and Fluocinonide, respectively), and Magnesium oxide and Fluocinonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: